132 related articles for article (PubMed ID: 22390276)
1. Tamoxifen-induced eccrine squamous syringometaplasia.
Teoh DC; Aw DC; Jaffar H; Ling W; Yong WP; Lee YS; Choo SN; Tan KB
J Cutan Pathol; 2012 May; 39(5):554-7. PubMed ID: 22390276
[TBL] [Abstract][Full Text] [Related]
2. Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases.
Gallo E; Llamas-Velasco M; Navarro R; Fraga J; García-Diez A
J Cutan Pathol; 2013 Mar; 40(3):326-9. PubMed ID: 23170995
[TBL] [Abstract][Full Text] [Related]
3. Vemurafenib-induced eccrine squamous syringometaplasia.
Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced eccrine squamous syringometaplasia in an infant.
Bittar PG; Casady M; Selim MA; Prose NS
Pediatr Dermatol; 2018 Jan; 35(1):e84-e85. PubMed ID: 29231256
[TBL] [Abstract][Full Text] [Related]
5. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
6. Imatinib-induced eccrine squamous syringometaplasia.
Van de Voorde K; De Raeve H; Van Regenmortel N; Lambert J
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S58-9. PubMed ID: 16843129
[No Abstract] [Full Text] [Related]
7. Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features.
Martorell-Calatayud A; Sanmartín O; Botella-Estrada R; Balmer NN; Serra-Guillén C; Gomez-Moyano E; Traves-Zapata V; Requena C; Nagore E; Llombart-Cussac B; Guillen-Barona C
J Am Acad Dermatol; 2011 Jun; 64(6):1092-103. PubMed ID: 21489654
[TBL] [Abstract][Full Text] [Related]
8. [Eccrine squamous syringometaplasia from chemotherapy extravasation].
Bordel MT; Miranda A
Actas Dermosifiliogr; 2005 Sep; 96(7):462-4. PubMed ID: 16476276
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-induced eccrine squamous syringometaplasia.
Molina-Ruiz AM; Molina-Ruiz RM; Zulueta T; Barabash R; Requena L
Am J Dermatopathol; 2012 Jun; 34(4):434-7. PubMed ID: 22257902
[TBL] [Abstract][Full Text] [Related]
10. Eccrine squamous syringometaplasia. A prospective clinicopathologic study.
Serrano T; Saez A; Moreno A
J Cutan Pathol; 1993 Feb; 20(1):61-5. PubMed ID: 7682228
[TBL] [Abstract][Full Text] [Related]
11. [Delayed appearance of maculopapular eruptions induced by tamoxifen].
Descamps V; Bouscarat F; Boui M; Marck Y; Lebrun-Vignes B; Crickx B; Belaich S
Ann Dermatol Venereol; 1999 Oct; 126(10):716-7. PubMed ID: 10604012
[TBL] [Abstract][Full Text] [Related]
12. Vincristine-induced eccrine squamous syringometaplasia.
Thomas LM; Mohr M; Smith M; Boyd A
Pediatr Dermatol; 2008; 25(6):623-5. PubMed ID: 19067868
[TBL] [Abstract][Full Text] [Related]
13. [Squamous syringometaplasia: an original manifestation of pathomimesis].
Cribier B; Lipsker D; Grosshans E
Ann Dermatol Venereol; 1993; 120(12):900-3. PubMed ID: 8074352
[TBL] [Abstract][Full Text] [Related]
14. Squamous syringometaplasia in association with annular elastolytic granuloma.
Helton JL; Metcalf JS
Am J Dermatopathol; 1995 Aug; 17(4):407-9. PubMed ID: 8600809
[TBL] [Abstract][Full Text] [Related]
15. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy.
Lerner TH; Barr RJ; Dolezal JF; Stagnone JJ
Arch Dermatol; 1987 Sep; 123(9):1202-4. PubMed ID: 3498441
[TBL] [Abstract][Full Text] [Related]
16. [Eccrine squamous syringometaplasia and cytomegalovirus infection].
Baysse L; Boralevi F; Lepreux S; Boyer A; Morel C; Léauté-Labrèze C; Taïeb A
Rev Med Interne; 2003 Jun; 24(6):394-8. PubMed ID: 12814829
[TBL] [Abstract][Full Text] [Related]
17. Targeting the adnexal epithelium: an unusual case of syringometaplasia in a patient on vemurafenib.
Yu J; Ravikumar S; Plaza JA; Troy JL; Schieke SM
Am J Dermatopathol; 2015 May; 37(5):e57-60. PubMed ID: 25839889
[TBL] [Abstract][Full Text] [Related]
18. Syringometaplasia: mucinous and squamous variants.
King DT; Barr RJ
J Cutan Pathol; 1979 Aug; 6(4):284-91. PubMed ID: 500875
[TBL] [Abstract][Full Text] [Related]
19. Eccrine squamous syringometaplasia in an allogenic stem cell transplant patient undergoing chemotherapy.
Nethers K; Messina J; Seminario-Vidal L
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469718
[TBL] [Abstract][Full Text] [Related]
20. Leukemia cutis and eccrine squamous syringometaplasia.
Bouceiro-Mendes R; Antunes-Duarte S; Aguado-Lobo M; Espinosa-Lara P; Soares-de-Almeida L; Filipe P
Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
